Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in Scottsdale, AZ
NPI: 1083823637Primary Employer
Mayo Clinic Building - Scottsdale
mayoclinic.org
HQ Phone
Get M.D., M.S., F.A.C.P. Javier's Phone Numberphone_androidMobile
Get M.D., M.S., F.A.C.P. Javier's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAZ State Medical License
MI State Medical License
TX State Medical License
AZ State Medical License
2012 - 2027
TX State Medical License
2011 - 2017
MI State Medical License
2005 - 2011
American Board of Internal Medicine
Hematology
American Board of Internal Medicine
Medical Oncology
Henry Ford Health/Henry Ford Hospital
Fellowship • Hematology and Medical Oncology
2008 - 2011
Residency • Internal Medicine
2005 - 2008
Cayetano Heredia University
Medical School
Until 2004
University of Texas M D Anderson Cancer Center
Fellowship • Investigational Cancer Therapeutics Fellowship In Early Drug Development
—
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 96413Infusion of chemotherapy into a vein up to 1 hour | 154 | 168 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 149 | 257 |
| 3 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 99 | 203 |
| 4 | 36591Collection of blood specimen from a completely implantable venous access device | 72 | 78 |
| 5 | J2405Injection, ondansetron hydrochloride, per 1 mg | 66 | 676 |
Rash in an immunocompromised patient.
Authors: Philip Kuriakose
Journal: JAMA
CODOX-M/IVAC-RDA-EPOCH-R in double-hit/triple-hit lymphoma patients aged 60 years or under
Authors: Grzegorz Nowakowski, Thomas Habermann, Madiha Iqbal, Thomas Witzig
Journal: Haematologica
Publication Date: 2025-02-01
Basophilic stippling: a lead to the diagnosis.
Authors: Yue Guo
Journal: Blood
Lead Sponsor: Kite, A Gilead Company
Intervention / Treatment: DRUG: Rituximab, DRUG: Cyclophosphamide, BIOLOGICAL: Axicabtagene Ciloleucel, DRUG: Fludarabine
Lead Sponsor: Allogene Therapeutics
Intervention / Treatment: DRUG: Cyclophosphamide, DRUG: Fludarabine, BIOLOGICAL: ALLO-647, GENETIC: ALLO-501
Lead Sponsor: Hoffmann-La Roche
Intervention / Treatment: DRUG: Doxorubicin, DRUG: Tocilizumab, DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Vincristine, DRUG: Polatuzumab Vedotin, DRUG: Mosunetuzumab, DRUG: Rituxumab